Glow Lifetech (GLOW) Q4 2024 earnings summary

Executive summary

• Achieved record Q4 2024 revenue, with strong gross margins and significant balance sheet improvements, reflecting a focus on sustainable, profitable growth.

• Fiscal 2024 marked transformational growth, scaling operations and establishing key customer relationships in Canada's cannabis market.

Financial highlights

• Q4 2024 net revenue reached $332,283, up 46% sequentially and 1,200% year-over-year.

• Gross profit for Q4 2024 was $225,172, up 35% sequentially and 1,504% year-over-year.

• Gross margin improved to 68% in Q4 2024, up from 55% in Q4 2023.

• EBITDA loss narrowed to $116,883 in Q4 2024, a 38% improvement from the previous quarter.

• Fiscal 2024 net revenue was $836,193, up 1,803% year-over-year; gross profit was $591,003, up 2,198% year-over-year; gross margin reached 71%.

Outlook and guidance

• Forecasting revenue and EBITDA growth in 2025, driven by brand expansion and strategic initiatives.

• Plans to expand market penetration across Canada, maintain lean operations, and invest in brand-building and R&D.

• Management expresses confidence in the strategy for sustained, profitable growth.